Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion type Assertion NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_head.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion description "[Therapeutic measures include interferon-alpha for CDA I, splenectomy for CDA II, and iron depletion for all individuals at risk for secondary hemochromatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_provenance.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion evidence source_evidence_literature NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_provenance.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion SIO_000772 15278299 NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_provenance.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion wasDerivedFrom befree-20140225 NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_provenance.
- NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_assertion wasGeneratedBy ECO_0000203 NP852608.RACsmzKKHgZa6NZlXBQj43uMFBS4vhNa10HucfgXyO5y0130_provenance.